Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Human Factors

Date Submitted: Jan 25, 2021
Date Accepted: Nov 27, 2021

The final, peer-reviewed published version of this preprint can be found here:

Implementation of E-prescription for Multidose Dispensed Drugs: Qualitative Study of General Practitioners’ Experiences

K. Gullslett M Sr, Strand Bergmo T Sr

Implementation of E-prescription for Multidose Dispensed Drugs: Qualitative Study of General Practitioners’ Experiences

JMIR Hum Factors 2022;9(1):e27431

DOI: 10.2196/27431

PMID: 35037881

PMCID: 8804951

The implementation of electronic multidose drug dispensing in general' practitioners' practice: A qualitative study

  • Monika K. Gullslett Sr; 
  • Trine Strand Bergmo Sr

ABSTRACT

Background:

Increased use of pharmaceuticals challenges both capacity and safety related to medication management for patients and changes in how general practitioners (GPs) and other health personnel interact with and follow up with patients. E-prescribing of multidose drug dispensing (eMDD) is one of the national measures being tested in Norway.

Objective:

The objective of this study was to explore GPs’ experiences with the challenges and benefits of implementing eMDD in Norway.

Methods:

Qualitative in-depth and group interviews were conducted with a total of 25 GPs between 2018 and 2020. Transcribed files were saved in NVivo to conduct a step-by-step content analysis. NVivo is a software tool for organising, managing, and analysing qualitative data.

Results:

The study revealed that eMDD offers many benefits. At the same time, there are several challenges related to information, training and initiation, as well as to the responsibility for the medication, interactions, and the risk of incorrect medication. An important activity in the start-up phase was an information meeting with pharmacies and technology suppliers, as well as exchanging information and instructions with pharmacies on how to get started. Four analytic themes emerged through the extraction of data: 1) Start-up with eMDD – “Be patient”, 2) The need for training, 3) Interaction, safety and efficiency, and 4) The working day with eMDD.

Conclusions:

There is variation in different GPs’ needs regarding training and information, and considerable variation in competence and motivation related to the use of digital tools. There were also different degrees of understanding concerning the everyday work of the other actors in the medication chain. In particular, the harmonisation of medication lists related to the use of time, expenditures, and challenges with technological solutions in the introduction phase was emphasised as a challenge. Overall, GPs who have started using the system report great benefits; these are largely related to an increased overview of patients’ total medication list, less time spent on prescribing prescriptions and increased collaboration with pharmacies and nurses both in service from providers in homes and in nursing homes.


 Citation

Please cite as:

K. Gullslett M Sr, Strand Bergmo T Sr

Implementation of E-prescription for Multidose Dispensed Drugs: Qualitative Study of General Practitioners’ Experiences

JMIR Hum Factors 2022;9(1):e27431

DOI: 10.2196/27431

PMID: 35037881

PMCID: 8804951

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.